APHON TEST QUESTIONS AND ANSWERS
ANSWER Daunorubicin EKG abnormalities, persistent CHF,
extravasation/infiltration, mucositis, and hepatotoxicity are among the side
effects.
Classification: topoisomerase inhibitor, cell cycle nonspecific
Colour: orange/red
Doxorubicin: A ANSWER Side effects include mucositis, hepatotoxicity,
extravasation/infiltration, pink/red body fluids hours after injection, and
persistent chf.
Classification: topoisomerase inhibitor, cell cycle nonspecific
Ruby red is the colour.
Idarubicin: A ANSWER Side effects include mucositis,
extravasation/infiltration, supraventricular tachycardia, and aberrant ECG
readings.
Orange in color
Classification: topoisomerase inhibitor, cell cycle nonspecific
ANSWER Mitoxantrone EKG abnormalities, arrhythmias,
extravasation/infiltration, and mucositis are examples of side effects.
Classification: topoisomerase inhibitor, cell cycle nonspecific
Blue in color
Hemorrhagic cystitis, ekg abnormalities, chf, hemorrhagic cardiac necrosis,
infertility, and nephrotoxicity are some of the side effects of cycophosphamide
(Cytoxan).
Alkylating agent, non-specific cell cycle classification
Considerations: delayed nausea, vomiting, and mesna
Five potential heart medications: ANSWER Mitoxantrone, cytoxan,
doxorubicin, idarubicin, and daunorubicin
ANSWER Corticosteroid Mood Drugs
, ANSWER: Corticosteroids Mood swings, Cushing's disease, osteopenia,
immunosuppression, and pancreatitis are among the side effects.
Cell cycle classification: nonspecific
Drugs that cause neurotoxicity: ANSWER Nelarabine and vinca alkaloids
(vincristine, vinblastine, and vinorelbine)
Ifosfomide
Vincristine's ANSWER Constipation, extravasation/infiltration, peripheral
neuropathy, neuropathic pain, and neurotoxicity are some of the adverse effects.
Classification: g2 m. tubulin inhibitor, cell cycle specific
Nelarabine: A ANSWER Adverse effects: neurotoxicity Peripheral neuropathy
Classification: antimetabolite, cell cycle specific
Ifosfomide-ANSWER Adverse consequences include nephrotoxicity,
hemorrhagic cystitis, infertility, neurotoxicity, and cns toxicity.
Classification: alkylating agent, non-specific cell cycle
Taking into account: Mesna,
Ototoxicity medications: ANSWER Cisplatin, carboplatin
Carboplatin: A ANSWER Otoxicity, infertility, nephrotoxicity, and
hypersensitivity are some of the adverse consequences.
Grouping: Classification: alkylating agent, non-specific cell cycle
ANSWER: Cisplatin Nephrotoxicity, infertility, hearing loss, and ototoxicity
are side effects.
Classification: alkylating agent, non-specific cell cycle
Drugs for capillary leaks and pulmonary edema: ANSWER Clofarabine,
Cytarabine
Clofarabine: A ANSWER Side effects include capillary leakage, pulmonary
edema,
Classification: antimetabolite, cell cycle specific